Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: VA vs DA for Newly Diagnosed Hig-risk AML Enrollment closed, study ongoing The First Affiliated Hospital of Soochow UniversityPhase 2/3 NCT05939180
  2. Minor: Mosunetuzumab Monotherapy · Select B-Cell Malignancies Primary completion pushed from Jul 31, 2027 to Oct 1, 2027 Genentech, Inc.Phase 2 NCT05207670
  3. Minor: Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy Enrollment closed, study ongoing M.D. Anderson Cancer CenterPhase 2/3 NCT05431595
  4. Minor: Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA) Enrollment closed, study ongoing NHS National Waiting Times Centre BoardPhase 2 NCT05198791
  5. Minor: Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors Enrollment closed, study ongoing Samsung Medical CenterPhase 2 NCT07381231
  6. Minor: LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention Trial completed Alexandra Hospital, Athens, GreecePhase 4 NCT07361679
  7. Minor: Efsubaglutide Alfa in Overweight/Obesity(SPARKLE) Trial completed Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Phase 2 NCT07114419
  8. Minor: Perioperative Use of Erector Spinae Plane Block (ESPB) and Intravenous Lidocaine Infusion in Anesthetic Management of Spinal Surgery in Children Trial completed Saint Petersburg State University, RussiaPhase 4 NCT06965933
  9. Minor: Vitamin A and D Supplementation in Allogeneic HCT Enrollment closed, study ongoing St. Petersburg State Pavlov Medical UniversityPhase 2 NCT06508099
  10. Minor: Pelvic Hypofractionated Radiotherapy in Endometrial Cancer Trial completed University of ChicagoPhase 1/2 NCT04683653
  11. Minor: H1710 for Injection · Advanced Solid Tumors Primary completion pushed from Sep 4, 2026 to Jan 31, 2027 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.Phase 1 NCT06992713
  12. Minor: Wound Healing Endpoint and Recurrence Trial completed Sashwati RoyPhase 1/2 NCT02577120
  13. Minor: Induction PD-1 Blockade (Nivolumab) · Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) Enrollment closed, study ongoing Yonsei UniversityPhase 2 NCT05795244
  14. Minor: Nivolumab and BO-112 Before Surgery · Resectable Soft Tissue Sarcoma Trial completed Jonsson Comprehensive Cancer CenterPhase 1 NCT04420975
  15. Minor: Venetoclax Basket Trial for High Risk Hematologic Malignancies Enrollment closed, study ongoing Andrew E. Place, MDPhase 1 NCT05292664
  16. Minor: Korean Real-world Study on MASLD/MASH Outcomes Primary and study completion pushed from Sep 30, 2026 to Dec 28, 2026 Novo Nordisk A/SNot specified NCT07739901
  17. Minor: Methylprednisolone Combined With the JAK Inhibitors · Toxic Epidermal Necrolysis Trial status changed: Unknown → Completed Peng ZhangEarly Phase 1 NCT06119490
  18. Minor: 177Lu-CTR-FAPI · Advanced, Metastatic Solid Tumors Trial completed Yan XingEarly Phase 1 NCT07229768
  19. Minor: BioHealx® Anal Fistula Device Post Market Surveillance Study Primary completion pushed from Oct 2026 to Feb 2027 Signum Surgical USA Inc.Not specified NCT07021742
  20. Minor: Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes Primary completion pushed from Apr 1, 2027 to Jun 1, 2027 ResilienceNot applicable NCT07087353
  21. Minor: Alpha Radiation Emitters Device · Advanced Pancreatic Cancer Primary and study completion pushed from Oct 2026 to Dec 2026 Alpha Tau Medical LTD.Not applicable NCT04002479
  22. Minor: CogT pSOPT Intervention Study Trial completed Stanford UniversityPhase 1 NCT06005038
  23. Minor: Heidelberg Engineering ANTERION Software Comparison Study Primary completion pushed from Oct 2026 to Dec 2026 Heidelberg Engineering GmbHNot specified NCT06657716
  24. Minor: Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment Trial completed University of OklahomaNot applicable NCT07701304
  25. Minor: Cigarette Addiction on Lower Extremity Movement Speed and Coordination Trial completed Saglik Bilimleri UniversitesiNot specified NCT07075068